Top Markets
Coin of the day
Resverlogix Corp. Resverlogix Corp.

Resverlogix Corp.

RVX
Rang în acțiuni #28673
Resverlogix Corporation is a biotechnology firm currently in advanced clinical... Resverlogix Corporation is a biotechnology firm currently in advanced clinical development, concentrating on developing treatments for illnesses where existing medical solutions are inadequate. The company's leading therapeutic compound is apabetalone (RVX-208), a selective small molecule designed to inhibit bromodomain and extra-terminal proteins. This compound is presently undergoing pivotal Phase III clinical trials for patients afflicted with conditions such as cardiovascular disease, diabetes, various stages of kidney disease (including end-stage renal disease), and neurodegenerative disorders. Furthermore, Resverlogix Corp. has forged an alliance with Eversana Life Science Services, LLC to support the forthcoming commercial rollout of apabetalone as a treatment for COVID-19 across the United States and Canada. The company's main office is located in Calgary, Canada.
Preț acțiune
$0.07339369
Ultima sincronizare: 2026-08-18
Capitalizare de piață
$25.24M
Schimbare (1 zi)
5.26%
Schimbare (1 an)
-9.55%
Țară
CA
Tranzacționează Resverlogix Corp. (RVX)

Categorie

Istoricul spliturilor pentru Resverlogix Corp. (RVX)
Acțiunea Resverlogix Corp. (simbol: RVX) a trecut printr-un total de 0 splituri.
Cel mai recent split a avut loc pe Aug 19, 2026.
O acțiune RVX cumpărată înainte de Aug 19, 2026 este echivalentă astăzi cu 0 acțiuni RVX.
Listă splituri acțiuni
An Split Multiplu Multiplu cumulativ
Nu sunt suficiente date pentru perioada selectată.
Splituri pentru companii similare sau competitori
Companie Număr total de splituri Multiplu cumulativ Țara
1 x2
US
0 -
US
0 -
NL
1 x3
AU
0 -
CH